A detailed history of Retirement Systems Of Alabama transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Retirement Systems Of Alabama holds 124,210 shares of NBIX stock, worth $15.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
124,210
Previous 124,955 0.6%
Holding current value
$15.6 Million
Previous $17.2 Million 0.78%
% of portfolio
0.07%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$130.86 - $143.19 $97,490 - $106,676
-745 Reduced 0.6%
124,210 $17.1 Million
Q1 2024

Apr 30, 2024

BUY
$130.4 - $143.74 $247,629 - $272,962
1,899 Added 1.54%
124,955 $17.2 Million
Q4 2023

Feb 05, 2024

BUY
$106.07 - $132.76 $119,646 - $149,753
1,128 Added 0.93%
123,056 $16.2 Million
Q3 2023

Nov 06, 2023

SELL
$94.02 - $117.1 $358,686 - $446,736
-3,815 Reduced 3.03%
121,928 $13.7 Million
Q2 2023

Jul 31, 2023

SELL
$89.53 - $104.87 $41,183 - $48,240
-460 Reduced 0.36%
125,743 $11.9 Million
Q1 2023

May 01, 2023

SELL
$94.11 - $123.02 $47,525 - $62,125
-505 Reduced 0.4%
126,203 $12.8 Million
Q4 2022

Feb 06, 2023

BUY
$106.72 - $127.06 $160,080 - $190,590
1,500 Added 1.2%
126,708 $15.1 Million
Q3 2022

Nov 04, 2022

SELL
$92.03 - $107.81 $64,236 - $75,251
-698 Reduced 0.55%
125,208 $13.3 Million
Q2 2022

Aug 03, 2022

BUY
$75.79 - $100.07 $108,303 - $143,000
1,429 Added 1.15%
125,906 $12.3 Million
Q1 2022

Apr 20, 2022

BUY
$72.45 - $94.81 $18,184 - $23,797
251 Added 0.2%
124,477 $11.7 Million
Q4 2021

Jan 20, 2022

BUY
$79.65 - $106.22 $133,573 - $178,130
1,677 Added 1.37%
124,226 $10.6 Million
Q3 2021

Nov 03, 2021

SELL
$86.18 - $99.03 $53,690 - $61,695
-623 Reduced 0.51%
122,549 $11.8 Million
Q2 2021

Jul 21, 2021

BUY
$89.43 - $102.27 $300,484 - $343,627
3,360 Added 2.8%
123,172 $12 Million
Q1 2021

Apr 15, 2021

BUY
$87.57 - $119.4 $10.5 Million - $14.3 Million
119,812 New
119,812 $11.7 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Retirement Systems Of Alabama Portfolio

Follow Retirement Systems Of Alabama and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.